World Acceptance (NASDAQ:WRLD) Stock, Quote.Headers.trade-ideas

World Acceptance

World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals.

xr:d:DAFqNaIkdw0:2,j:153520640059868796,t:23073113

News

Intraday Update

Markets

Movers

Trading Ideas

AEYE

ATUS

AVGR

AVTR

BIIB

BJRI

CHTR

CMAX

COLB

COUR

CREV

DECK

DOUG

DXCM

EVRI

FWRD

GROM

KARO

KITT

LBRDA

NMHI

Next Technology Holding Inc. - Ordinary Shares

NXTT

OPTT

PAPL

POAI

PSIG

SAIA

SDST

SGMO

SLNA

TANH

TARS

TNDM

TWOU

UCTT

VSAT

WINT

WRLD

ZYXI

Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Penny Stocks

Small Cap

ACON

AEHL

AGTI

AKLI

ATCH

BENF

BFLY

BREA

CLDX

CTCX

DHAI

DOGZ

FRPT

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IBRX

ITRI

KRYS

LUNR

MARA

MIST

NBSE

NEPT

NUWE

OCGN

PSNY

ROMA

SELX

SGRY

SKYT

TBIO

TEVA

THMO

TRNR

VERO

ZJYL

ZVSA

Shares of  Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

MGNX

MRNA

NYXH

ORLA

PODD

SMMT

TMDX

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday.

Shares of  Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak quarterly sales.

Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday

World Acceptance Corporation - Common Stock

World Acceptance Corp

PARIS ALIGNED CMT WRLD ETF USD ACC

Shares of Saia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) fell sharply during Friday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/SAIA/earnings">second-quarter financial results</a>.
Saia reported quarterly earnings of $3.83 per share which missed the analyst consensus estimate of $4.00 per share. The company reported quarterly sales of $823.24 million which missed the analyst consensus estimate of $826.55 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Saia shares dipped 18.6% to $398.01 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) gained 117.4% to $0.4639 after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.</li>
<li>Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares jumped 101.3% to $6.67 after the company filed a request for the withdrawal of its registration statement on a Form S-1.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) gained 53% to $13.94.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares gained 46.2% to $10.83 after the company beat second-quarter earnings estimates.</li>
<li>Carbon Revolution Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREV#NASDAQ">CREV</a>) shares climbed 43.3% to $8.84. Carbon Revolution said it will supply the carbon fiber wheels available on the just-revealed Chevrolet Corvette ZR1.</li>
<li>Everi Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVRI#NYSE">EVRI</a>) rose 41.1% to $12.93 after it entered an agreement to be acquired by funds managed by Apollo affiliates for $14.25 per share in cash.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) gained 37% to $4.45.</li>
<li>Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) jumped 36.6% to $8.66 on better-than-expected second-quarter earnings and raising FY24 outlook.</li>
<li>Sangamo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) gained 35% to $0.9043.</li>
<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) rose 28% to $1.55 after the company announced results from a bias analysis conducted for its concluded Phase 3 study of Multikine. Multikine cut the 5-year risk of death by half compared to control in its target population.</li>
<li>AudioEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) rose 25% to $24.52 following second-quarter results.</li>
<li>Pineapple Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAPL#NYSE">PAPL</a>) gained 24.4% to $1.1760. Pineapple Financial CSO Christa Lillian Mitchell bought a total of 2,000 shares at an average price of $0.88.</li>
<li>Douglas Elliman Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOUG#NYSE">DOUG</a>) climbed 23% to $1.66.</li>
<li>CareMax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) rose 19% to $6.71.</li>
<li>Liberty Broadband Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBRDA#NASDAQ">LBRDA</a>) rose 17.6% to $65.16.</li>
<li>Charter Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) jumped 17% to $368.65 after the company reported better-than-expected second-quarter financial results.</li>
<li>Mohawk Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) gained 16.5% to $156.70 following mixed second-quarter earnings.</li>
<li>Karooooo Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) gained 16% to $33.40. Karooooo announced termination of secondary public offering of ordinary shares due to market conditions.</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) climbed 15% to $118.99 after better-than-expected second-quarter financial results and FY24 EPS outlook raise.</li>
<li>International Game Technology PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>) gained 13.4% to $22.86 after the company entered an agreement for its Gaming &amp; Digital business to be acquired by funds managed by affiliates of Apollo.</li>
<li>Altice USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATUS#NYSE">ATUS</a>) rose 12.1% to $1.76.</li>
<li>Stardust Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) rose 11% to $15.06.</li>
<li>Avantor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) surged 11% to $25.32 after the company reported better-than-expected second-quarter earnings results.</li>
<li>Norfolk Southern Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) gained 10.7% to $246.86 after the company reported better-than-expected second-quarter earnings results.</li>
<li>Selina Hospitality PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares gained 10.4% to $0.0415 after falling over 17% on Thursday.</li>
<li>Viasat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) rose 9% to $20.58. Viasat announced new reporting segment structure.</li>
<li>Deckers Outdoor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) shares gained 8.7% to $914.71 as the company reported better-than-expected results for the first quarter. The company said it still expects net sales to increase approximately 10% year-over-year in fiscal year 2025 to $4.7 billion.</li>
<li>Bristol-Myers Squibb Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) climbed 7.6% to $48.69 following strong second-quarter earnings and increased 2024 guidance.</li>
<li>Centene Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) climbed 7.6% to $72.55 following better-than-expected second-quarter financial results and increased 2024 guidance.</li>
<li>Columbia Banking System, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) rose 7.4% to $25.98 after the company reported better-than-expected quarterly earnings results. Also, multiple firms raised their respective price targets on its stock.</li>
<li>Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) gained 6.8% to $319.30 after the company reported better-than-expected quarterly revenue results.</li>
<li>Ultra Clean Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) shares gained 4.7% to $47.26 following better-than-expected quarterly results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>NovaBay Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) shares dipped 59.6% to $0.7830 after the company reported pricing of $3.5 million underwritten public offering.</li>
<li>Tantech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TANH#NASDAQ">TANH</a>) fell 46.9% to $0.2603.</li>
<li>Nature&#8217;s Miracle Holding Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) fell 46.4% to $0.2099 after the company announced pricing of $1.2 million public offering.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) shares declined 40.7% to $63.97 after the company reported worse-than-expected second-quarter revenue results and issued weak FY24 revenue guidance.</li>
<li>Predictive Oncology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>) fell 29.6% to $1.3150. Predictive Oncology announced exercise of warrants for $1.26 million gross proceeds.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMN#NASDAQ">PMN</a>) declined 29.2% to $1.5006 as the company reported top-line data from its Phase 1a Alzheimer&#8217;s trial and announced up to $122.7 million private placement financing.</li>
<li>PS International Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) dipped 26.1% to $1.53</li>
<li>Grom Social Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROM#NASDAQ">GROM</a>) fell 23.8% to $0.2751.</li>
<li>Ocean Power Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#NASDAQ">OPTT</a>) shares declined 23.2% to $0.3188 after reporting fourth-quarter results.</li>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) fell 20.2% to $1.30.</li>
<li>Next Technology Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) declined 20.1% to $1.6299.</li>
<li>Zynex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) shares fell 18.9% to $8.27 after the company reported worse-than-expected second-quarter financial results.</li>
<li>2U, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) declined 17.6% to $1.24.</li>
<li>Ur-Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URG#NYSE">URG</a>) shares dipped 13.4% to $1.1250 after the company announced a proposed public offering of common shares.</li>
<li>BJ&#8217;s Restaurants, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJRI#NASDAQ">BJRI</a>) fell 12.6% to $32.53 following quarterly results.</li>
<li>Booz Allen Hamilton Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) declined 11.8% to $135.36 following a first-quarter earnings miss and soft EPS guidance.</li>
<li>Advent Technologies Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADN#NASDAQ">ADN</a>) shares fell 11.2% to $4.40 after gaining 3% on Thursday.</li>
<li>Tarsus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) fell 9.1% to $25.67.</li>
<li>World Acceptance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) dipped 7.8% to $134.62 following weak quarterly sales.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) fell 7.4% to $25.61.</li>
<li>Olin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) shares declined 7.2% to $44.56 following a second-quarter earnings miss.</li>
<li>Carter&#8217;s, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) shares fell 6.6% to $55.87 following weak quarterly sales.</li>
<li>Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) declined 6.3% to $213.01 after the European Medicines Agency adopted a negative opinion on the Marketing Authorization Approval for lecanemab.</li>
<li>Tandem Diabetes Care, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) shares fell 6% to $38.18. Tandem Diabetes Care will release its second quarter results after the closing bell on Thursday, Aug. 1.</li>
<li>L3Harris Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) declined 4.6% to $232.05 following second-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39984491/nvidia-lockheed-martin-and-2-other-stocks-insiders-are-selling">Nvidia, Lockheed Martin And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session

WIIM

World Acceptance shares are trading lower after the company reported worse-than-expected Q1 revenue results.

World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) reported quarterly earnings of $1.79 per share which beat the analyst consensus estimate of $1.69 by 5.92 percent. This is a 10.49 percent increase over earnings of $1.62 per share from the same period last year. The company reported quarterly sales of $129.527 million which missed the analyst consensus estimate of $141.000 million by 8.14 percent. This is a 7.03 percent decrease over sales of $139.324 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

World Acceptance Q1 2025 GAAP EPS $1.79 Beats $1.69 Estimate, Sales $129.527M Miss $141.000M Estimate

Buybacks

On May 15, World Acceptance Board Approved Share Repurchase Program For Up To $20M Of Common Stock Inclusive Of Any Amount Remains Available Under Prior Repurchase Authorizations - Filing

World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) reported quarterly earnings of $6.09 per share which beat the analyst consensus estimate of $4.35 by 40 percent. This is a 45 percent increase over earnings of $4.20 per share from the same period last year. The company reported quarterly sales of $159.265 million which beat the analyst consensus estimate of $149.353 million by 6.64 percent. This is a 0.98 percent decrease over sales of $160.837 million the same period last year.

World Acceptance Q4 2024 GAAP EPS $6.09 Beats $4.35 Estimate, Sales $159.265M Beat $149.353M Estimate

Shares of Freshpet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frpt#NASDAQ">FRPT</a>) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.
Freshpet posted quarterly earnings of 31 cents per share, beating market estimates of 5 cents per share. The company&rsquo;s quarterly sales came in at $215.42 million versus expectations of $204.36 million.
Freshpet shares gained 15.5% to $106.29 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Akili, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akli#NASDAQ">AKLI</a>) shares jumped 126% to $0.5009 after the company reported positive results from Shionogi&#39;s Phase 3 clinical trial of localized version of Akili&#39;s EndeavorRx&reg; for Pediatric ADHD patients in Japan.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zvsa#NASDAQ">ZVSA</a>) climbed 126% to $1.81 after surging over 30% on Friday.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) gained 107% to $13.71 after tumbling 40% on Friday.</li>
<li>Neptune Wellness Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nept#NASDAQ">NEPT</a>) rose 54.6% to $0.49.</li>
<li>Interactive Strength Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trnr#NASDAQ">TRNR</a>) surged 32.2% to $0.8701 after the company announced it has entered into an exclusive worldwide distribution agreement with WOODWAY to sell and distribute CLMBR.</li>
<li>Agiliti, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agti#NASDAQ">AGTI</a>) gained 29.4% to $9.89 after the company announced it will be taken private by THL Partners.</li>
<li>Krystal Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krys#NASDAQ">KRYS</a>) surged 28.8% to $143.34 after the company reported better-than-expected financial results.</li>
<li>R1 RCM Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rcm#NYSE">RCM</a>) surged 26.7% to $14.06 after the company received an acquisition offer for the company valued at $13.75 per share.</li>
<li>Butterfly Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfly#NASDAQ">BFLY</a>) gained 26.3% to $1.2880.</li>
<li>Altimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alt#NASDAQ">ALT</a>) surged 22.1% to $11.24.</li>
<li>Milestone Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mist#NASDAQ">MIST</a>) gained 21.3% to $2.10 after the company announced plans to resubmit the New Drug Application (NDA) for etripamil to the U.S. Food and Drug Administration (FDA) for paroxysmal supraventricular tachycardia (PSVT).</li>
<li>Ocugen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocgn#NASDAQ">OCGN</a>) climbed 18.9% to $0.9451.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) gained 18% to $ 4.1250.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) rose 16.2% to $40.44 after the company reported fourth-quarter financial results above estimates and issued first-quarter guidance.</li>
<li>Nuwellis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nuwe#NASDAQ">NUWE</a>) shares rose 16.1% to $0.7101.</li>
<li>SkyWater Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skyt#NASDAQ">SKYT</a>) gained 15.4% to $10.98.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) gained 14.3% to $3.9999 after dipping 33% on Friday.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cldx#NASDAQ">CLDX</a>) surged 13.9% to $43.00 following strong quarterly sales.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psny#NASDAQ">PSNY</a>) gained 13.4% to $1.4850.</li>
<li>Itron, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itri#NASDAQ">ITRI</a>) rose 12.3% to $84.11 after the company reported fourth-quarter financial results and issued first-quarter guidance above estimates.</li>
<li>HashiCorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcp#NASDAQ">HCP</a>) gained 11.8% to $24.77 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $23 to $30.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) jumped 11.2% to $26.67.</li>
<li>NeuBase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbse#NASDAQ">NBSE</a>) shares surged 10.5% to $0.83. Neubase Therapeutics, on Feb. 22, said board determined for company to dissolve, liquidate and distribute to stockholders its available assets.</li>
<li>Carmell Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctcx#NASDAQ">CTCX</a>) rose 9.9% to $2.47. Carmell announced product development has been completed for Gold Limited Edition Exclusive launch in March 2024.</li>
<li>Domino&#39;s Pizza, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dpz#NYSE">DPZ</a>) gained 8.2% to $469.01 after the company&rsquo;s fourth quarter 2023 earnings surpassed Wall Street expectations, raised its quarterly dividend, and announced an additional share buyback plan.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) rose 6.5% to $5.75. The company on Monday announced that it entered into a technology license agreement with Forseven Limited.</li>
<li>Teva Pharmaceutical Industries Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teva#NYSE">TEVA</a>) shares gained 4.3% to $13.44 after the company announced FDA approval of its arthritis treatment.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aclarion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) shares fell 62.5% to $0.34 after the company priced its public offering of 5.175 million units. Each unit includes one share of common stock (or a pre-funded warrant), and two common warrants.</li>
<li>Venus Concept Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vero#NASDAQ">VERO</a>) dipped 28.8% to $0.93 after the company announced a $1.2 million registered direct offering at $1.465 per share.</li>
<li>DIH Holding US, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dhai#NASDAQ">DHAI</a>) fell 28.3% to $0.79.</li>
<li>ThermoGenesis Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thmo#NASDAQ">THMO</a>) dipped 27.5% to $0.7601.</li>
<li>Intuitive Machines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lunr#NASDAQ">LUNR</a>) fell 25.1% to $7.18 after the company said its lunar lander may have tipped over upon landing on the moon.</li>
<li>Semilux International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/selx#NASDAQ">SELX</a>) declined 24.4% to $0.8615.</li>
<li>Brera Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brea#NASDAQ">BREA</a>) fell 21.8% to $0.8601.</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehl#NASDAQ">AEHL</a>) dipped 21.8% to $1.50. Antelope Enterprise announced closing of $1.3 million registered direct offering and private placement.</li>
<li>NGM Biopharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ngm#NASDAQ">NGM</a>) fell 19.4% to $1.5399. NGM Bio has entered into a definitive agreement and plan of merger with certain affiliates of the Column Group, LP.</li>
<li>Telesis Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tbio#NASDAQ">TBIO</a>) shares fell 17.8% to $0.6401. Telesis Bio shares jumped 72% on Friday after the company was granted EUR Patent #3503915 for &quot;Genetically Engineered Vibrio Natriegens (Host Organism For Cloning And Manipulating DNA).&quot;</li>
<li>Beneficient (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/benf#NASDAQ">BENF</a>) fell 17% to $0.1640. On Feb. 13, Beneficient posted a third-quarter loss of $1.98 per share.</li>
<li>Dogness (International) Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dogz#NASDAQ">DOGZ</a>) fell 17% to $6.14.</li>
<li>AtlasClear Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atch#NYSE">ATCH</a>) shares fell 11.2% to $2.3450 after jumping over 131% on Friday.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) declined 11.2% to $6.30.</li>
<li>Roma Green Finance Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roma#NASDAQ">ROMA</a>) fell 9.9% to $1.4599 after tumbling 11% on Friday.</li>
<li>Surgery Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgry#NASDAQ">SGRY</a>) dipped 7.8% to $30.43 following weak quarterly sales.</li>
<li>World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) fell 7% to $120.71. World Acceptance recently reported better-than-expected third-quarter financial results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/02/37283655/intuit-to-rally-around-14-here-are-10-top-analyst-forecasts-for-friday"> Intuit To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday </a>

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday.
Shares of Surgery Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgry#NASDAQ">SGRY</a>) fell sharply during Monday&rsquo;s session following <a href="https://www.benzinga.com/quote/SGRY/earnings">weak quarterly sales</a>.
Surgery Partners posted adjusted earnings of 44 cents per share, versus market estimates of 38 cents per share. The company&rsquo;s quarterly sales came in at $735.40 million missing expectations of $741.40 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Surgery Partners shares tumbled 7.8% to $30.43 on Monday.
Here are some other big stocks recording losses in today&rsquo;s session.
<ul>
<li>Intuitive Machines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lunr#NASDAQ">LUNR</a>) dipped 25.1% to $7.18 after the company said its lunar lander may have tipped over upon landing on the moon.</li>
<li>Nyxoah S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nyxh#NASDAQ">NYXH</a>) fell 11.3% to $15.29. Nyxoah is expected to release fourth quarter financial results on March 5, 2024.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) fell 11.2% to $6.30.</li>
<li>TransMedics Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmdx#NASDAQ">TMDX</a>) dipped 8.6% to $75.99. TransMedics Group is expected to release financial results for the fourth quarter after market close on Feb. 26, 2024.</li>
<li>World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) declined 7% to $120.71. World Acceptance recently reported better-than-expected third-quarter financial results.</li>
<li>MacroGenics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgnx#NASDAQ">MGNX</a>) fell 7% to $16.88.</li>
<li>Kosmos Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kos#NYSE">KOS</a>) dipped 7% to $5.55. Kosmos Energy reported a fourth-quarter fiscal 2023 revenue decline of 10% year-over-year to $507.81 million, beating the consensus of $477.73 million.</li>
<li>Orla Mining Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orla#NASDAQ">ORLA</a>) fell 6.8% to $3.38.</li>
<li>Insulet Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/podd#NASDAQ">PODD</a>) fell 5.8% to $173.54 after Barclays maintained an Equal-Weight rating on the stock and lowered its price target from $214 to $213.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) declined 5.6% to $4.38.</li>
<li>Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) fell 4.3% to $92.36 after HSBC downgraded the stock from Hold to Reduce but raised its price target from $75 to $86.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/02/37310145/top-3-defensive-stocks-that-may-collapse-in-february"> Top 3 Defensive Stocks That May Collapse In February </a>

Shares of TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) fell sharply during Friday&rsquo;s session.
TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.
TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Charge Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crge#NASDAQ">CRGE</a>) shares surged 105.4% to $0.2510.</li>
<li>Kaman Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kamn#NASDAQ">KAMN</a>) shares climbed 101.3% to $45.14 after the company announced it will be acquired by Arcline for $1.8 billion.</li>
<li>Mesa Air Group Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mesa#NASDAQ">MESA</a>) gained 70.4% to $1.09 as the company entered into new agreements with United Airlines for improved operating and financing terms.</li>
<li>Edgewise Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ewtx#NASDAQ">EWTX</a>) rose 37.3% to $13.30 after the company announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcsa#NASDAQ">PCSA</a>) climbed 34.2% to $0.2725. Processa Pharmaceuticals announced plans to expand the development of next generation capecitabine (NGC-Cap) into advanced or metastatic breast cancer beginning with next Phase 2 trial in breast cancer.</li>
<li>Tricon Residential Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tcn#NYSE">TCN</a>) shares gained 28.2% to $11.06 Blackstone and Tricon Residential entered into an arrangement agreement under which Blackstone Real Estate Partners X together with Blackstone Real Estate Income Trust, Inc. will acquire all outstanding common shares of Tricon for $11.25 per share in cash.</li>
<li>Spirit Airlines, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/save#NYSE">SAVE</a>) jumped 24% to $7.06 after the company announced preliminary fourth-quarter and full year 2023 estimates, issued first-quarter 2024 guidance and said the merger agreement between the company and JetBlue &quot;remains in full force and effect.&quot;</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) climbed 23.1% to $383.31 after the company announced updated financial guidance for the second-quarter, which surpassed its previous outlook.</li>
<li>Allied Gaming &amp; Entertainment Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agae#NASDAQ">AGAE</a>) rose 20.6% to $1.1190.</li>
<li>Portage Biotech Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prtg#NASDAQ">PRTG</a>) gained 19% to $1.14.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmn#NASDAQ">PMN</a>) gained 19% to $2.07.</li>
<li>Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shph#NASDAQ">SHPH</a>) gained 16.4% to $0.5185.</li>
<li>Treasure Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgl#NASDAQ">TGL</a>) shares rose 14.2% to $0.1176. Treasure Global and AIO Synergy recently entered into a strategic alliance aimed at reshaping the landscape of artificial intelligence.</li>
<li>Silk Road Medical, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silk#NASDAQ">SILK</a>) jumped 13.1% to $14.91 after Stifel upgraded the stock from Hold to Buy and raised its price target from $9 to $20.</li>
<li>Wayfair Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/w#NYSE">W</a>) jumped 11.6% to $56.81 after the company announced a workforce realignment plan, which includes a workforce reduction involving approximately 13% of its global workforce.</li>
<li>Bullfrog AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfrg#NASDAQ">BFRG</a>) gained 10.6% to $4.30.</li>
<li>NewAmsterdam Pharma Company N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nams#NASDAQ">NAMS</a>) rose 10.5% to $19.44.</li>
<li>World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) gained 10.2% to $134.00 following upbeat quarterly results.</li>
<li>Ally Financial Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ally#NYSE">ALLY</a>) gained 9.4% to $35.15. Synchrony Financial announced plans to acquire Ally Financial&#39;s point of sale financing business. Ally Financial also posted upbeat quarterly sales.</li>
<li>Cyngn Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) surged 8.8% to $0.1468 after gaining over 5% on Thursday.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) gained 8.1% to $1.86 after the FDA granted a Rare Pediatric Disease Designation to the company&rsquo;s Revascor&reg; for treating children with congenital heart disease.</li>
<li>WNS (Holdings) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wns#NYSE">WNS</a>) rose 4.4% to $65.71. Needham analyst Mayank Tandon maintained WNS with a Buy and raised the price target from $80 to $85.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) shares fell 63.2% to $0.1384 as the company announced pricing of $7.0 million upsized underwritten public offering.</li>
<li>Azitra, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aztr#NYSE">AZTR</a>) dipped 31.8% to $1.3976 after the company filed for a firm commitment public offering of 3 million shares of common stock.</li>
<li>iRobot Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/irbt#NASDAQ">IRBT</a>) fell 30% to $16.53 following a report suggesting the EU plans to block Amazon&#39;s acquisition of the company.</li>
<li>Accelerate Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axdx#NASDAQ">AXDX</a>) fell 27.1% to $1.17 after the company reported pricing of approximately $15 million public offering and private placement.</li>
<li>AST SpaceMobile, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asts#NASDAQ">ASTS</a>) declined 24.3% to $3.15. AST SpaceMobile announced a $100 million offering of common stock. The company also announced a strategic investment from AT&amp;T Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/t#NYSE">T</a>),</li>
<li>Alphabet Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goog#NASDAQ">GOOG</a>) (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) and Vodafone.</li>
<li>Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) dipped 21.9% to $1.0699. Agrify entered into a multi-million dollar sales agreement with Ocean Deep/Golden Lake Business Park.</li>
<li>Adagene Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adag#NASDAQ">ADAG</a>) fell 21.6% to $2.64.</li>
<li>BioCardia, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcda#NASDAQ">BCDA</a>) fell 20% to $0.46.</li>
<li>Volato Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/soar#NYSE">SOAR</a>) fell 17.2% to $2.1688.</li>
<li>Datasea Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dtss#NASDAQ">DTSS</a>) shares fell 16.4% to $0.1140. Datasea announced plans for a 1-for-15 reverse stock split to regain compliance with Nasdaq minimum bid requirement.</li>
<li>Orgenesis Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orgs#NASDAQ">ORGS</a>) dipped 15.3% to $0.2711.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) fell 12.6% to $3.19.</li>
<li>Nkarta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nktx#NASDAQ">NKTX</a>) fell 12.2% to $7.47.</li>
<li>Vision Marine Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vmar#NASDAQ">VMAR</a>) shares fell 11.5% to $0.7098. Vision Marine Technologies announced close of $3.0 million private placement of convertible preferred shares and warrants with Investissement Qu&eacute;bec.</li>
<li>Absci Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/absi#NASDAQ">ABSI</a>) dipped 11.3% to $3.2120.</li>
<li>Lithium Americas Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lac#NYSE">LAC</a>) fell 10.4% to $4.3650.</li>
<li>Celsius Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celh#NASDAQ">CELH</a>) fell 10% to $53.60 after B of A Securities downgraded the stock from Buy to Neutral and announced a $65 price target.</li>
<li>Hut 8 Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hut#NYSE">HUT</a>) dipped 9.4% to $6.45.</li>
<li>Lifezone Metals Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lzm#NYSE">LZM</a>) fell 9.3% to $6.37.</li>
<li>MorphoSys AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mor#NASDAQ">MOR</a>) fell 7.3% to $9.49 after falling 6% on Wednesday. Morgan Stanley analyst James Quigley, on Tuesday, downgraded MorphoSys from Overweight to Equal-Weight.</li>
<li>Hertz Global Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htz#NASDAQ">HTZ</a>) declined 6.6% to $8.40 after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $12 to $8.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) shares fell 6.1% to $2.0188. Esperion priced its $85.1 million public offering of 56.7 million common share at $1.50 per share.</li>
<li>Chegg, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chgg#NYSE">CHGG</a>) shares fell 6.1% to $9.45. Goldman Sachs analyst Eric Sheridan downgraded Chegg from Neutral to Sell and lowered the price target from $10 to $8.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/01/36690939/jim-cramer-predicts-a-terrific-year-for-this-manufacturer-and-as-for-u-haul-im-fine-with"> Jim Cramer Predicts A &#39;Terrific Year&#39; For This Manufacturer, And As For U-Haul? &#39;I&#39;m Fine With It&#39;</a>

ABSI

ADAG

AGAE

AGFY

ALLY

ASTS

AXDX

AZTR

BCDA

BFRG

CELH

CHGG

CISS

CRGE

DTSS

ESPR

EWTX

GOOG

GOOGL

IRBT

KAMN

MESA

MESO

Morgan Stanley Capital Protected Notes for S&P 500 Index

NAMS

NKTX

ORGS

PCSA

PRTG

RNAZ

SAVE

SHPH

SILK

SMCI

SOAR

VMAR

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

World Acceptance shares are trading higher after the company reported better-than-expected Q3 financial results.

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday.
Shares of World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) rose sharply during Friday&rsquo;s session following <a href="https://www.benzinga.com/quote/WRLD/earnings">upbeat quarterly results.</a>
World Acceptance posted quarterly earnings of $2.84 per share, beating market estimates of $1.88 per share. The company&rsquo;s quarterly sales came in at $137.75 million versus expectations of $130.58 million.
World Acceptance shares jumped 10.2% to $134.00 on Friday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Kaman Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kamn#NASDAQ">KAMN</a>) shares gained 101.3% to $45.14 after the company announced it will be acquired by Arcline for $1.8 billion.</li>
<li>Edgewise Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ewtx#NASDAQ">EWTX</a>) jumped 37.3% to $13.30 after the company announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.</li>
<li>Tricon Residential Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tcn#NYSE">TCN</a>) shares rose 28.2% to $11.06 Blackstone and Tricon Residential entered into an arrangement agreement under which Blackstone Real Estate Partners X together with Blackstone Real Estate Income Trust, Inc. will acquire all outstanding common shares of Tricon for $11.25 per share in cash.</li>
<li>Spirit Airlines, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/save#NYSE">SAVE</a>) climbed 24% to $7.06 after the company announced preliminary fourth-quarter and full year 2023 estimates, issued first-quarter 2024 guidance and said the merger agreement between the company and JetBlue &quot;remains in full force and effect.&quot;</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) gained 23.1% to $383.31 after the company announced updated financial guidance for the second-quarter, which surpassed its previous outlook.</li>
<li>Silk Road Medical, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silk#NASDAQ">SILK</a>) shares rose 13.1% to $14.91 after Stifel upgraded the stock from Hold to Buy and raised its price target from $9 to $20.</li>
<li>Wayfair Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/w#NYSE">W</a>) surged 11.6% to $56.81 after the company announced a workforce realignment plan, which includes a workforce reduction involving approximately 13% of its global workforce.</li>
<li>NewAmsterdam Pharma Company N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nams#NASDAQ">NAMS</a>) gained 10.5% to $19.44.</li>
<li>Ally Financial Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ally#NYSE">ALLY</a>) surged 9.4% to $35.15. Synchrony Financial announced plans to acquire Ally Financial&#39;s point of sale financing business. Ally Financial also posted upbeat quarterly sales.</li>
<li>MacroGenics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgnx#NASDAQ">MGNX</a>) rose 7.7% to $11.59.</li>
<li>Fiverr International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fvrr#NYSE">FVRR</a>) rose 6.9% to $26.41. Goldman Sachs analyst Eric Sheridan upgraded Fiverr Intl from Neutral to Buy.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) gained 6.4% to $2.5750.</li>
<li>WNS (Holdings) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wns#NYSE">WNS</a>) gained 4.4% to $65.71. Needham analyst Mayank Tandon maintained WNS with a Buy and raised the price target from $80 to $85.</li>
<li>State Street Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stt#NYSE">STT</a>) rose 4.3% to $77.51 after the company reported better-than-expected fourth-quarter financial results and announced a new authorization to repurchase up to $5 billion of common shares.</li>
<li>Texas Instruments Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/txn#NASDAQ">TXN</a>) gained 3.8% to $173.18. UBS analyst Timothy Arcuri upgraded Texas Instruments from Neutral to Buy and raised the price target from $170 to $195.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/01/36690939/jim-cramer-predicts-a-terrific-year-for-this-manufacturer-and-as-for-u-haul-im-fine-with"> Jim Cramer Predicts A &#39;Terrific Year&#39; For This Manufacturer, And As For U-Haul? &#39;I&#39;m Fine With It&#39;</a>

FVRR

PLUG

World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday

World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) reported quarterly earnings of $2.84 per share which beat the analyst consensus estimate of $1.88 by 51.06 percent. This is a 186.87 percent increase over earnings of $0.99 per share from the same period last year. The company reported quarterly sales of $137.75 million which beat the analyst consensus estimate of $130.58 million by 5.49 percent. This is a 5.97 percent decrease over sales of $146.50 million the same period last year.

World Acceptance Q3 EPS $2.84 Beats $1.88 Estimate, Sales $137.75M Beat $130.58M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $2.00 billion.
&bull; State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) is estimated to report quarterly earnings at $1.83 per share on revenue of $2.95 billion.
&bull; Huntington Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) is projected to report quarterly earnings at $0.27 per share on revenue of $1.77 billion.
&bull; Travelers Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) is projected to report quarterly earnings at $5.02 per share on revenue of $9.99 billion.
&bull; Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) is estimated to report quarterly earnings at $0.84 per share on revenue of $8.96 billion.
&bull; Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) is likely to report quarterly earnings at $1.36 per share on revenue of $839.36 million.
&bull; World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) is estimated to report quarterly earnings at $1.88 per share on revenue of $130.58 million.
&bull; Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) is expected to report quarterly earnings at $0.46 per share on revenue of $1.80 billion.
&bull; Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) is expected to report quarterly earnings at $0.85 per share on revenue of $2.16 billion.
<h3>&nbsp;</h3>
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

FITB

HBAN

Earnings Scheduled For January 19, 2024

World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) is set to give its latest quarterly earnings report on Friday, 2024-01-19. Here's what investors need to know before the announcement.
Analysts estimate that World Acceptance will report an earnings per share (EPS) of $1.88. 
World Acceptance bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.94, which was followed by a 0.0% drop in the share price the next day.
Here's a look at World Acceptance's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.77</td>
<td>1.13</td>
<td>1.60</td>
<td>0.55</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.71</td>
<td>1.62</td>
<td>1.97</td>
<td>-0.78</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.9%</td>
<td>10.32%</td>
<td>6.45%</td>
<td>-4.96%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1705586462_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of World Acceptance were trading at $126.65 as of January 15. Over the last 52-week period, shares are up 58.55%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/WRLD/earnings">To track all earnings releases for World Acceptance visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For World Acceptance

On Nov 9, 2023, World Acceptance Corp Approved A Share Repurchase Program Authorizing The Company To Repurchase Up To $20M Of Its Outstanding Common Stock Inclusive Of Any Amount That Remains Available For Repurchase Under Prior Repurchase Authorizations

Gainers
INVO Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/invo#NASDAQ">INVO</a>) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.
LumiraDx Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmdx#NASDAQ">LMDX</a>) shares climbed 187.4% to $0.25 after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England&rsquo;s first community-based heart and lung screening hub.
Akumin Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aku#NASDAQ">AKU</a>) shares climbed 125% to $0.3279 after the company reached an agreement with Stonepeak to become a private company.
Textainer Group Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgh#NYSE">TGH</a>) shares gained 44.5% to $49.33 after the company agreed to be acquired by Stonepeak for $7.4 billion.
Twin Ridge Capital Acquisition Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trca#NYSE">TRCA</a>) climbed 17.7% to $8.11.
Bright Green Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgxx#NASDAQ">BGXX</a>) rose 17.6% to $0.4156.
Navios Maritime Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nm#NYSE">NM</a>) gained 17.2% to $2.21. N Logistics Holdings announced plans to acquire all outstanding shares of common stock of Navios Maritime Holdings not already owned by NLHC for $2.28 per share.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) gained 16.2% to $0.5576.
TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) rose 16% to $1.2775
FLJ Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flj#NASDAQ">FLJ</a>) jumped 15.8% to $0.3323.
NOVONIX Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvx#NASDAQ">NVX</a>) climbed 15.4% to $2.10
The Alkaline Water Company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wter#NASDAQ">WTER</a>) shares rose 14.6% to $0.2290 after falling 14% on Friday.
Nexalin Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxl#NASDAQ">NXL</a>) surged 13.6% to $0.3580.
Farfetch Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftch#NYSE">FTCH</a>) rose 13% to $1.7850.
EngageSmart, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/esmt#NYSE">ESMT</a>) gained 12.1% to $22.65 after the company announced it would be acquired by Vista Equity Partners for $23 per share.
Digital Brands Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbgi#NASDAQ">DBGI</a>) rose 11.2% to $5.36.
Abacus Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abl#NASDAQ">ABL</a>) climbed 8.4% to $6.81.
Riot Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) shares gained 7.6% to $9.55 following a spike in Bitcoin.
Hut 8 Mining Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hut#NASDAQ">HUT</a>) gained 7% to $1.9889 amid a rise in Bitcoin.
Losers
Revolution Medicines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvmd#NASDAQ">RVMD</a>) fell 43.2% to $15.85 after the company announced it presented clinical activity and safety data from its Phase 1/1b trial of RMC-6236.
Li-Cycle Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/licy#NYSE">LICY</a>) shares fell 42.4% to $1.3087 after the company announced plans to halt construction work on its Rochester Hub project, pending completion of a comprehensive review of the go-forward strategy for the project..
Apollomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aplm#NASDAQ">APLM</a>) dipped 38% to $1.08 after the company announced the presentation of vebreltinib efficacy and safety data from the KUNPENG clinical trial at ESMO 2023.
XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) fell 36.6% to $0.4050 after jumping more than 100% on Friday.
Aclarion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) fell 36% to $0.3597. Aclarion signed a LOI with ATEC to advance commercialization of Nociscan.
Great Ajax Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ajx#NYSE">AJX</a>) declined 33% to $4.26 after the company and Ellington Financial announced the mutual termination of their merger agreement.
Spectaire Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spec#NASDAQ">SPEC</a>) fell 27.5% to $3.60.
Troika Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) shares fell 27.3% to $0.8001 after reporting financial results for the quarter ended June 30, 2023.
WANG &amp; LEE GROUP, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlgs#NASDAQ">WLGS</a>) fell 26.3% to $0.56 after gaining over 38% on Friday.
Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) declined 23.7% to $0.38.
Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) fell 23% to $1.86.
MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) fell 21.1% to $1.1350.
Ambrx Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amam#NASDAQ">AMAM</a>) declined 20.9% to $6.66. Ambrx announced ARX517, a PSMA-targeted ADC, demonstrates 52% PSA50 (&ge;50% Reduction) and a highly differentiated safety and PK profile in patients with mCRPC, who progressed on multiple FDA-approved treatments.
Ryvyl Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvyl#NASDAQ">RVYL</a>) fell 20% to $2.31.
C4 Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccc#NASDAQ">CCCC</a>) declined 18.2% to $1.53.
FaZe Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faze#NASDAQ">FAZE</a>) shares fell 17.4% to $0.1643. GameSquare Holdings and FaZe Holdings recently entered into a definitive agreement pursuant to which GameSquare will acquire FaZe Clan in an arm&#39;s length all-stock transaction.
Erayak Power Solution Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/raya#NASDAQ">RAYA</a>) fell 16.4% to $0.7101.
Biocept, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bioc#NASDAQ">BIOC</a>) fell 16.3% to $0.4730.
Harpoon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/harp#NASDAQ">HARP</a>) shares fell 15.8% to $5.80 after the company. Harpoon announced a private placement of PIPE equity of up to $150 million. The company disclosed announced updated data from a trial evaluating its cancer drug.
Falcon&#39;s Beyond Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fbyd#NASDAQ">FBYD</a>) dipped 15.6% to $14.57.
FMC Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) fell 12.7% to $58.52 after the company updated its third-quarter and FY23 outlook.
VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) fell 12.3% to $4.72. The company recently entered into a standby equity agreement with YA LL PN for an aggregate subscription amount of up to $1 billion.
ContraFect Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cfrx#NASDAQ">CFRX</a>) shares fell 11.9% to $0.3172 in pre-market trading after declining 10% on Friday. The company recently reported FDA clearance of CF-370 IND application to proceed with Phase 1 clinical study.
Catalyst Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbio#NASDAQ">CBIO</a>) fell 11.7% to $0.4414 in pre-market trading after climbing around 25% on Friday.
Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) fell 10.5% to $0.2417 in pre-market trading after gaining 10% on Friday.
Golden Sun Education Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gsun#NASDAQ">GSUN</a>) shares fell 10.1% to $0.4691 after declining 5% on Friday.
Okta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okta#NASDAQ">OKTA</a>) declined 8.9% to $68.87 on continued downward momentum after a threat actor breached its support system and viewed certain customer files. Also, Keybanc maintained an Overweight rating on the stock but lowered its price target from $106 to $95.
World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) fell 8% to $102.50 after BMO Capital maintained an Underperform rating on the stock and lowered its price target from $58 to $56.
NewAmsterdam Pharma Company N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nams#NASDAQ">NAMS</a>) declined 7.4% to $6.50. NewAmsterdam Pharma named Ian Somaiya as Chief Financial Officer.
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/10/35374121/bitcoin-tops-this-key-level-fantom-emerges-as-top-gainer"> Bitcoin Tops This Key Level; Fantom Emerges As Top Gainer</a>

AMAM

APLM

BGXX

BIOC

BRSH

CBIO

CCCC

CFRX

DBGI

ESMT

FAZE

FBYD

FTCH

GSUN

HARP

Intelligent Bio Solutions Inc. - Common Stock

INBS

INVO

LICY

LMDX

MOTS

Nuveen California Dividend Advantage Municipal Fund 2

OKTA

RAYA

RIOT

RVMD

RVYL

SPEC

TRCA

Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

World Acceptance

World Acceptance (WRLD) Forecast

World Acceptance (NASDAQ:WRLD) Stock, Quote.Headers.trade-ideas